Discussion
The common clinical manifestations of infantile galactosialidosis mainly result from generalised sphingolipid storage and consequently mimic those seen in GM1 gangliosidosis. These include hypotonia, hepatosplenomegaly, dysostosis multiplex, frequently with significant periosteal new bone formation, and progressive neuromotor degeneration with or without retinal cherry spots.' The patients may also display macrocephaly with coarse facial features, generalised oedema, and ascites.5 Routine screening tests for inborn errors of metabolism usually give normal results, therefore delaying the diagnosis. Testing for vacuolated lymphocytes for screening purposes appears to be useful. A definitive diagnosis, however, requires oligosaccharide chromatography followed by the appropriate enzyme studies. Galactosialidosis can be diagnosed by showing a deficiency of the lysosomal P-galactosidase and neuraminidase or by assay of lysosomal carboxypeptidase activity obligatory for the maturation of the protective protein precursor, which in turn is necessary for the formation of a stable multienzyme complex containing the ,B-galactosidase and neuraminidase. 6 The patient presented here displayed several congenital malformations which, as far as we could find, have not been reported previously in patients with classical galactosialidosis. However, our patient did not seem to be a clear cut case of this entity and may represent a variant form of it, associated with major congenital malformations. On the other hand, the malformations observed may represent coincidental findings. Finally, it is also possible that both the biochemical and organic pathology recorded are the result of a submicroscopic chromosome abnormality. 
